The past two years have been a fruitful collaboration between our laboratory and the European Innovation Center from Shimadzu.A joint study for early detection of Alzheimer’s disease biomarkers using mass spectrometry opens the door to new research...
This week, the M2 – DMCC students had the opportunity to visit our platform within the IRMB, accompanied by Professor Hirtz. We are always happy to show our platform to people interested in research!
Meet our team: a combination of engineers, technicians and PhD students. All our individual skills and knowledge combined makes our platform so much more interesting!
We are pleased to share with you the latest poster from our PhD student Marie-Laure PONS on the analysis of the synucleins by LC-MRM in biological fluids (plasma, CSF and saliva) in the context of neurodegenerative diseases such as Parkinson’s disease.
Latest news! Our new Simoa HD-X from Quanterix has arrived to replace our previous model HD-1. This model is a fully automated Simoa bead-based immunoassay platform and delivers major productivity improvements, greater user flexibility, unparalleled sensitivity, and...
Thanks to LCGC to share the work done by our team on quantification of tau and ptau by LC-MS/MS for Alzheimer’s disease ! Jerome VIALARET, Christophe HIRTZ, Sylvain LEHMANN, Laura FICHTER More information :...
